L Lauder, F Mahfoud, M Böhm - Annual Review of Medicine, 2024 - annualreviews.org
Resistant hypertension (RH) is a severe form of hypertension associated with increased cardiovascular risk. Although true RH affects less than 10% of the patients receiving …
SH Mufarrih, NQ Qureshi, MS Khan… - Journal of the …, 2024 - ahajournals.org
Background Despite optimal medical therapy, a significant proportion of patients' blood pressure remains uncontrolled. Catheter‐based renal denervation (RDN) has been …
DE Kandzari, RR Townsend, K Kario, F Mahfoud… - Journal of the American …, 2023 - jacc.org
Background Renal denervation (RDN) reduces blood pressure (BP) in patients with uncontrolled hypertension in the absence of antihypertensive medications. Objectives This …
BACKGROUND: The randomized, sham-controlled RADIANCE-HTN (A Study of the Recor Medical Paradise System in Clinical Hypertension) SOLO, RADIANCE-HTN TRIO, and …
AS Maini, M Maini, T Addo, V Koshti, T Koshy… - Trends in …, 2024 - Elsevier
Renal denervation as an option for difficult to treat hypertension has been a concept for several decades, with recent US FDA approval of new, minimally invasive devices …
Background Hypertension is a major public health issue due to its association with cardiovascular disease risk. Despite the availability of effective antihypertensive drugs, rates …
P Drawz, D Baumann, A Dayton - Current opinion in nephrology …, 2023 - journals.lww.com
Studies of renal denervation continue to find a robust antihypertensive effect, especially in studies wherein medications are withdrawn. Further investigation into mechanisms and …
O Azzam, SH Nejad, R Carnagarin… - British Journal of …, 2024 - Wiley Online Library
Resistant hypertension is associated with an exceedingly high cardiovascular risk and there remains an unmet therapeutic need driven by pathophysiologic pathways unaddressed by …